ADVM: מזומנים למניה Adverum Biotechnologies, Inc.

סמל תאגידי ולוגו של Adverum Biotechnologies, Inc. (ADVM)

Adverum Biotechnologies (ADVM) is developing the innovative AAV.7m8 vector to replace frequent injections for AMD, establishing a foundation for expansion. Cash per share confirms liquidity, where the parameter value equals 1.17. Management's strategy focuses on the long-term improvement of patient vision, while the localization of all processes in the US mitigates geopolitical risks.

מזומנים למניה אחת: adverum.com (ADVM) עבור 04.07.2022 - 20.12.2025

פילוחי מדדים מקיפים ואנליטיקה עבור Adverum Biotechnologies, Inc. (ADVM)

- פרטי פוזיציית מזומנים ותזרימי מזומנים:
ניתוח מקיף של החברה:ADVM (Adverum)
פריט של המותג adverum.com

For Adverum Biotechnologies (ADVM), which develops innovative gene therapy methods for the eyes, this indicator serves as a measure of financial autonomy. The metric is calculated by dividing the total volume of liquid assets by the number of shares outstanding. The trend of the cash position per share on the GURU.Markets platform reflects the actual burn rate of capital on clinical trials. An increase in this indicator guarantees protection against default during the development of breakthrough technologies, while a decrease signals intensive investment in the evidence base for the gene delivery method.